Literature DB >> 17228011

Cardiac resynchronization therapy in New York Heart Association class IV heart failure: it is all about selection.

W H Wilson Tang, Gary S Francis.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17228011     DOI： 10.1161/CIRCULATIONAHA.106.669879

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  3 in total

1.  Prognostic significance of beta-blocker up-titration in conjunction with cardiac resynchronization therapy in heart failure management.

Authors:  Takeru Nabeta; Takayuki Inomata; Yuichiro Iida; Yuki Ikeda; Miwa Iwamoto-Ishida; Shunsuke Ishii; Takashi Naruke; Tomohiro Mizutani; Hisahito Shinagawa; Toshimi Koitabashi; Ichiro Takeuchi; Junya Ako
Journal:  Heart Vessels       Date:  2015-08-08       Impact factor: 2.037

Review 2.  The potential role of cardiac resynchronization therapy in acute heart failure syndromes.

Authors:  Norman C Wang; Sanjoy Bhattacharya; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2011-09       Impact factor: 4.214

3.  New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure.

Authors:  Katalin Úri; Miklós Fagyas; Ivetta Mányiné Siket; Attila Kertész; Zoltán Csanádi; Gábor Sándorfi; Marcell Clemens; Roland Fedor; Zoltán Papp; István Édes; Attila Tóth; Erzsébet Lizanecz
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.